Submission of Unaudited Quarterly Financial Results of the Company for the quarter and nine months ended 31st December, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Nexus Surgical and Medicare Ltd reported unaudited results for Q3 FY26 showing sales of Rs. 293.08 lakhs, up about 97% from Rs. 148.39 lakhs in Q3 FY25. For the nine months ended December 2025, sales rose to Rs. 582.19 lakhs from Rs. 423.91 lakhs, a growth of roughly 37%. Profit after tax for the quarter was Rs. 17.01 lakhs (vs Rs. 11.36 lakhs YoY), while nine-month PAT stood at Rs. 49.62 lakhs (vs Rs. 40.91 lakhs), with EPS of Rs. 0.91. The company operates mainly in trading and received a clean limited review report from its auditor. A point to note is that other equity remains negative at Rs. (440.83) lakhs, indicating accumulated losses still exceed the paid-up capital.
Strong top-line growth in Q3 and improving profitability are positive signals for shareholders, though the persistently negative reserves remain a structural concern. The stock may see a short-term positive reaction on the sharp sequential and yearly revenue jump.